Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test

This study has been completed.
Abbott Diagnostics Division
National Science Council, Taiwan
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Information provided by (Responsible Party):
National Taiwan University Hospital Identifier:
First received: September 16, 2009
Last updated: October 19, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):